| 37619975 | Trends in cardiovascular mortality in the United States from 1968 to 2019: analysis of the CDC WONDER database. | Eur J Prev Cardiol | 2024 |
| 36597656 | Demographic and regional trends of peripheral artery disease-related mortality in the United States, 2000 to 2019. | Vasc Med | 2023 |
| 37916575 | Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States. | Future Cardiol | 2023 |
| 37517922 | Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials. | Atherosclerosis | 2023 |
| 37607461 | Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosis. | Atherosclerosis | 2023 |
| 36950675 | The association of sex-specific hormones with coronary artery plaque characteristics from Miami Heart (MiHeart) study. | Am J Prev Cardiol | 2023 |
| 37418345 | Emergency Department Observation Unit Patients Want Evaluation and Treatment for Hypercholesterolemia: A Health Belief Model Study. | Crit Pathw Cardiol | 2023 |
| 36971960 | With Current Safety and Efficacy Data, Should Statins Be Made Available as Nonprescription Over-the-Counter Drugs? | Curr Cardiol Rep | 2023 |
| 37001288 | Characteristics and outcomes in acute myocardial infarction hospitalizations among the older population (age â¿¥80 years) in the United States, 2004-2018. | Arch Gerontol Geriatr | 2023 |
| 37329876 | Rarely tested or treated but highly prevalent: Hypercholesterolemia in ED observation unit patients with chest pain. | Am J Emerg Med | 2023 |
| 37028649 | Ideal Cardiovascular Health and Adipokine Levels: The Multi-Ethnic Study of Atherosclerosis. | Endocr Pract | 2023 |
| 36926956 | Social Determinants of Cardiovascular Risk, Subclinical Cardiovascular Disease, and Cardiovascular Events. | J Am Heart Assoc | 2023 |
| 36881667 | Circulating ketone bodies and cardiovascular outcomes: the MESA study. | Eur Heart J | 2023 |
| 36511156 | Association of Lp(a) (Lipoprotein[a]) and Hypertension in Primary Prevention of Cardiovascular Disease: The MESA. | Hypertension | 2023 |
| 34625741 | Apolipoproteins in vascular biology and atherosclerotic disease. | Nat Rev Cardiol | 2022 |
| 35644222 | National trends and disparities in statin use for ischemic heart disease from 2006 to 2018: Insights from National Ambulatory Medical Care Survey. | Am Heart J | 2022 |
| 35342890 | Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement. | Am J Prev Cardiol | 2022 |
| 35759823 | Omega-3 fatty acids, subclinical atherosclerosis, and cardiovascular events: Implications for primary prevention. | Atherosclerosis | 2022 |
| 36075621 | Coronary Atherosclerosis in an Asymptomatic U.S. Population: Miami Heart Study at Baptist Health South Florida. | JACC Cardiovasc Imaging | 2022 |
| 36342682 | Assessment of Atherosclerotic Cardiovascular Disease Risk in Primary Prevention. | J Cardiopulm Rehabil Prev | 2022 |
| 36180367 | Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). | J Clin Lipidol | 2022 |
| 35902351 | Effect of olezarsen targeting APOC-III on lipoprotein size and particle number measured by NMR in patients with hypertriglyceridemia. | J Clin Lipidol | 2022 |
| 36031845 | Prolonged and Pronounced Low-Density Lipoprotein Cholesterol Lowering: The Gift That Keeps Giving. | Circulation | 2022 |
| 35956226 | Newer and Emerging LDL-C Lowering Agents and Implications for ASCVD Residual Risk. | J Clin Med | 2022 |
| 36192199 | Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). | Am J Cardiol | 2022 |
| 36253168 | Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA). | Atherosclerosis | 2022 |
| 33826862 | Association Between Breast Arterial Calcification on Mammography and Coronary Artery Disease: A Systematic Review and Meta-Analysis. | J Womens Health (Larchmt) | 2022 |
| 35227438 | Drug Interactions: What Are Important Drug Interactions for the Most Commonly Used Medications in Preventive Cardiology? | Med Clin North Am | 2022 |
| 35188972 | Relationship of American Heart Association's Life Simple 7, Ectopic Fat, and Insulin Resistance in 5 Racial/Ethnic Groups. | J Clin Endocrinol Metab | 2022 |
| 35072922 | Should a Statin be Given to All Hypertensive Patients? | Curr Hypertens Rep | 2022 |
| 35182577 | Association of participation in Cardiac Rehabilitation with Social Vulnerability Index: The behavioral risk factor surveillance system. | Prog Cardiovasc Dis | 2022 |
| 35277208 | Cardiotoxicity risk factors with immune checkpoint inhibitors. | Cardiooncology | 2022 |
| 35063437 | Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. | Prog Cardiovasc Dis | 2022 |
| 34935456 | Trends in Premature Mortality From Acute Myocardial Infarction in the United States, 1999 to 2019. | J Am Heart Assoc | 2022 |
| 34967800 | Physical Activity, Coronary Artery Calcium, and Cardiovascular Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA). | Med Sci Sports Exerc | 2022 |
| 35025993 | Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk. | Eur Heart J | 2022 |
| 35078346 | Trends in Characteristics and Outcomes in Primary Heart Failure Hospitalizations Among Older Population in the United States, 2004 to 2018. | Circ Heart Fail | 2022 |
| 32976895 | Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry. | J Pediatr | 2021 |
| 33827231 | Association of Carotid Artery Plaque With Cardiovascular Events and Incident Coronary Artery Calcium in Individuals With Absent Coronary Calcification: The MESA. | Circ Cardiovasc Imaging | 2021 |
| 33704452 | Heart, mind, and soul: spirituality in cardiovascular medicine. | Eur Heart J | 2021 |
| 34876126 | Plasma metabolomic profiling in subclinical atherosclerosis: the Diabetes Heart Study. | Cardiovasc Diabetol | 2021 |
| 34593126 | Hepatic Sensing Loop Regulates PCSK9Â Secretion in Response to Inhibitory Antibodies. | J Am Coll Cardiol | 2021 |
| 34503676 | High-Sensitivity C-Reactive Protein Modifies the Cardiovascular Risk of Lipoprotein(a): Multi-Ethnic Study of Atherosclerosis. | J Am Coll Cardiol | 2021 |
| 34327491 | Ten things to know about ten cardiovascular disease risk factors. | Am J Prev Cardiol | 2021 |
| 34274280 | Coronary Artery Calcification and Risk Stratification in Familial Hypercholesterolemia: Moving Forward But Not There Yet. | JACC Cardiovasc Imaging | 2021 |
| 34325835 | Closing the Glycemic Divide: The Time for Preventive Cardiology Is Now. | J Am Coll Cardiol | 2021 |
| 34041918 | Association Between Omega-3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA. | J Am Heart Assoc | 2021 |
| 34298554 | Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies. | Eur J Prev Cardiol | 2021 |
| 34181090 | Polygenic Risk Scores to Identify CVD Risk and Tailor Therapy: Hope or Hype? | Curr Atheroscler Rep | 2021 |
| 34127543 | Roadmap to a career in preventive cardiology. | Heart | 2021 |